CHEManager Interview with Taros in Issue March 2020
“From Idea to Product – the principle of an extended workbench accelerates innovation in chemistry” March Issue of CHEManager´s Section Chemistry & Life Sciences
Dortmund, March 2020 ++++
Taros Chemicals is a private-owned contract research and contract manufacturing organization (CRO/CMO) with sites in Dortmund and Hyderabad, India. Since its foundation in 1999, Taros has developed from a pure custom synthesis provider to strong driver of innovation and a acknowledged research partner for customers from pharmaceuticals, biotech, crop protection and classic chemical industry, as well as for universities and start-ups. The Company works on projects from all areas of organic chemistry. This includes the whole process of drug discovery chemistry for the development of new drug candidates, Research and production of highly specialized polymers, e.g. for photographic applications, and the synthesis of complex molecules in optoelectronic applications or future-oriented batteries and energy storage systems are used. Ralf Kempf conducted an interview with Youri Mesmoudi, Executive Vice President of Taros, on the Service portfolio of the company in the area of performance chemicals and the strategic development of this business area.
About Taros Chemicals
Taros is a privately owned discovery chemistry company, working with global pharmaceutical, biotech and chemical companies since 1999. Alongside our performance chemicals and material science division, Taros’ drug discovery mission is to create drug candidates as potential new medicines. Taros has a strong scientific track record on many biomolecular targets in all main therapeutic areas and thereby adding considerable value to collaborations from target validation and hit identification to lead generation and optimization. Taros’ core expertise ranges from custom synthesis and process development to modern medicinal and computational chemistry, as well as compound library design and production.
Taros was heading the chemistry efforts of the EUR 196 million funded European Lead Factory (2013-2018) and is currently heading its EUR 36.5 million funded continuation (2019-2022). Moreover, Taros is deeply engaged in other research alliances like the EUR 11 million funded Drug Discovery Hub Dortmund.
Youri R. Mesmoudi, Executive Vice President, e-mail: innovation |at| taros.de
The CHEManager brand of publications and information services comprises leading business newspapers and various online services for the chemical and pharmaceutical industry. The German-language print edition CHEManager was established in 1991 and has since become the must-read trade and business newspaper for executives and managers in the chemical and pharmaceutical markets in Germany, Austria and Switzerland.
Read more about the article on www.chemanager-online.com/
As a leading contract research organization in discovery chemistry and custom synthesis, Taros provides comprehensive solutions to meet our clients’ needs from diverse branches and applications
Our experienced chemists practice a pragmatic culture and customer-centric approach in order to exceed project expectations, despite challenges, bridging very narrow timelines. They are trained to consider economic, safety and ecological boundaries and conditions laid out for all stages of the project, starting from the development of synthetic routes to…